SCH 351591
SCH 351591 is a potent, selective and orally active phosphodiesterase-4 (PDE4) inhibitor with an IC50 of 58 nM. SCH 351591 can inhibit all 4 PDE4 subtypes (A, B, C, and D) . SCH 351591 has the potential for the asthma and chronic obstructive pulmonary disease (COPD) research[1].
Product Specifications
CAS Number
444659-43-2
UNSPSC
12352005
Target
Phosphodiesterase (PDE)
Type
Reference compound
Related Pathways
Metabolic Enzyme/Protease
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/sch-351591.html
Purity
99.22
Solubility
DMSO : 100 mg/mL (ultrasonic)
Smiles
O=C(C1=C2C=CC(C(F)(F)F)=NC2=C(OC)C=C1)NC3=C(Cl)C=[N+]([O-])C=C3Cl
Molecular Formula
C17H10Cl2F3N3O3
Molecular Weight
432.18
References & Citations
[1]Patricia E Losco, et al. The toxicity of SCH 351591, a novel phosphodiesterase-4 inhibitor, in Cynomolgus monkeys. Toxicol Pathol. 2004 May-Jun;32 (3) :295-308.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
Phase 1
Isoform
PDE4
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
HA723866 100 µL
Mouse/Rat GDF15 Recombinant Rabbit monoclonal Antibody
Sign In for Pricing
View Details 
BNC472501-100 1x 100 µL
CD68 (Macrophage Marker) (C68/2501), CF647 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 